Back to search

West Virginia University

Dapsone activation of CYP2C9 allelic variants

Abstract

dc:description.abstract

Studies have shown that CYP2C9.1 mediated metabolism of flurbiprofen and naproxen is activated by dapsone. However, dapsone activation has not been studied in the allelic variant forms of CYP2C9. Six concentrations of flurbiprofen or naproxen were co-incubated with six concentrations of dapsone and with reconstituted, purified CYP2C9.1, CYP2C9.2 (R144C), CYP2C9.3 (1359L), or CYP2C9.5 (D360E), in order to assess degrees of activation. Dapsone increased the efficiency (Vmax/Km) of flurbiprofen metabolism 690%, 3029%, 4600%, and 2100% by CYP2C9.1, CYP2C9.2, CYP2C9.3, and CYP2C9.5, respectively. Dapsone increased the efficiency of naproxen metabolism 591%, 1400%, 1150%, and 2100%, by CYP2C9.1, CYP2C9.2, CYP2C9.3, and CYP2C9.5, respectively. Also, dapsone normalized the kinetic profile of naproxen from biphasic (CYP2C9.1 and CYP2C9.2) or linear (CYP2C9.3 and CYP2C9.5) to hyperbolic for all variant forms. The amino acid substitutions of CYP2C9 allelic variants appear to affect the degree of dapsone activation.

Degree

thesis:*
Name thesis:degree_name
MS
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Pharmaceutical Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hummel, Matthew Aaron

Subjects

dc:subject × 1

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
West Virginia University
Base URL
researchrepository.wvu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Hummel, Matthew Aaron. Dapsone activation of CYP2C9 allelic variants. Thesis thesis, https://doi.org/10.33915/etd.1737